Discontinuation due to neuropsychiatric adverse events with efavirenz- and dolutegravir-based antiretroviral therapy: a comparative real-life study.

Noelia Fernández-BargielaSandra Rotea-SalvoLuis Margusino-FramiñánVanesa Balboa-BarreiroIsabel Martín-HerranzÁngeles Castro-IglesiasÁlvaro Mena-De-CeaSoledad López-CalvoPilar Vázquez-RodríguezEnrique Míguez-ReyPurificación Cid-Silva

Published in: European journal of hospital pharmacy : science and practice (2020)

We found a high rate of discontinuations due to AEs and NPAEs, prescription of benzodiazepines and a requirement for consultation in a psychiatric unit in both treatment groups, especially with EFV.

Keyphrases

antiretroviral therapy
hiv infected
hiv infected patients
human immunodeficiency virus
hiv positive
hiv aids
mental health
palliative care
combination therapy
hepatitis c virus